Improving mechanistic understanding of responsiveness to spinal cord stimulation after spinal cord injury
提高对脊髓损伤后脊髓刺激反应机制的理解
基本信息
- 批准号:10672452
- 负责人:
- 金额:$ 12.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAxonBilateralBiological MarkersCase StudyClassificationClinical ManagementElectromyographyEventFoundationsFundingGenerationsGoalsHandednessHealthHumanImplantIndividualInjuryInstitutionInterventionInvestigationIpsilateralKnowledgeLegLife ExpectancyLightLower ExtremityMagnetic Resonance ImagingManuscriptsMeasuresMotorMovementMuscleNational Institute of Child Health and Human DevelopmentNeuronal PlasticityNeurostimulation procedures of spinal cord tissueOperative Surgical ProceduresParticipantPatternPersonsPhysical FunctionPilot ProjectsProductivityPrognosisQuality of lifeRecoveryReportingResearchResearch PersonnelResidual stateResolutionSensorySideSignal TransductionSpinal CordSpinal cord damageSpinal cord injurySupine PositionTimeTissuesTouch sensationTrainingTravelUnited States National Institutes of HealthWalkingWorkbiomarker identificationclinical examinationcohortcostdesignelectric fieldimplantationimprovedimproved outcomemagnetic resonance imaging biomarkermanneural networkneuroimagingneuroimaging markerneuroregulationpersonalized approachphysically handicappedprospectiverehabilitation researchsoundtheoriestooltreatment strategytrend
项目摘要
PROJECT SUMMARY / ABSTRACT
Spinal cord injury (SCI) is a devastating event in terms of a person’s health, physical function, costs (direct and
indirect), and life expectancy. It has been conventionally thought that individuals with severe SCIs, with no motor
function below the level of injury, will not recover the ability to functionally move their lower extremities or
voluntarily walk. However, spinal cord stimulation (SCS) has emerged as a promising intervention challenging
this long-held assumption. While spinal cord stimulation allows for restored voluntary movement after severe
SCI, there is a lack of mechanistic understanding regarding how it works and why some individuals respond
better than others. Thus, the overall objective of this proposal is to apply neuroimaging biomarkers to generate
fundamental knowledge regarding responsiveness to spinal cord stimulation (SCS).
Aim 1: Use neuroimaging biomarkers to understand responsiveness to epidural SCS in participants with
severe SCI, during volitional movement and standing tasks. Using high-resolution MRI in a prospective
design, the applicant hypothesizes that the laterality of cord damage, detected prior to surgical implantation, will
predict ipsilateral lower extremity muscle responsiveness to epidural SCS prior to any training.
Aim 2: Use neuroimaging biomarkers to understand responsiveness to transcutaneous SCS in
participants with severe SCI, during volitional movement tasks and sensory examination. Using high-
resolution MRI in a prospective design, the applicant hypothesizes that total spinal cord spared tissue will predict
bilateral lower extremity muscle responsiveness to transcutaneous SCS prior to any training, and that posterior
cord spared tissue will predict light touch sensory recovery prior to any training.
Significance: Successful completion of these Aims will advance the NIH/NICHD NCMRR aim: “to enhance the
health, productivity, independence, and quality of life of people with physical disabilities.” One important problem
in the field of SCS is a lack of foundational knowledge on why the intervention works. Neuroimaging holds
pronounced potential to address this problem. Neuroimaging biomarkers will not only improve the understanding
of responsiveness to this intervention after SCI, but will also help drive individualized approaches for using SCS,
selection of epidural versus transcutaneous SCS, prognosis for improvement using SCS, and the identification
of who is likely to optimally respond before activity-based recovery training. Completion of the proposed aims
will lead to the high likelihood of sustained, powerful influence on the SCS field, laying a vital foundation for using
MRI biomarkers to guide SCS intervention, ultimately improving the clinical management of persons with SCI.
项目总结/摘要
脊髓损伤(SCI)是一个人的健康,身体功能,成本(直接和间接)方面的破坏性事件。
间接)和预期寿命。传统上认为,患有严重SCI的人,没有运动
功能低于损伤水平,将无法恢复功能性移动下肢的能力,或
自愿步行。然而,脊髓刺激(SCS)已成为一种有前途的干预措施,
这个长期的假设。虽然脊髓刺激可以在严重的脊髓损伤后恢复自主运动,
SCI,缺乏对它如何工作以及为什么有些人会做出反应的机械理解
比其他人更好因此,该提议的总体目标是应用神经成像生物标志物来生成
关于脊髓刺激(SCS)反应性的基本知识。
目的1:使用神经影像学生物标志物了解参与者对硬膜外SCS的反应性,
严重SCI,在意志运动和站立任务期间。在前瞻性研究中使用高分辨率MRI
设计,申请人假设在手术植入前检测到的脊髓损伤的偏侧性,
在任何训练之前预测同侧下肢肌肉对硬膜外SCS的反应性。
目的2:使用神经影像学生物标志物了解经皮SCS的反应性,
严重SCI的参与者,在意志运动任务和感觉检查。使用高-
在一项前瞻性设计中,申请人假设脊髓备用组织总数将预测
在任何训练之前,双侧下肢肌肉对经皮SCS的反应性,以及
在任何训练之前,脊髓备用组织将预测轻触感觉恢复。
意义:这些目标的成功完成将推进NIH/NICHD NCMRR的目标:“加强
身体残疾者的健康、生产力、独立性和生活质量。”一个重要问题
在SCS领域中,缺乏关于为什么干预有效的基础知识。神经影像学检查
解决这一问题的潜力。神经影像学生物标记物不仅能提高对
SCI后对这种干预的反应性,但也将有助于推动使用SCS的个性化方法,
硬膜外与经皮SCS的选择、使用SCS改善的预后以及识别
的人可能在基于活动的恢复训练之前做出最佳反应。完成拟议目标
将导致对SCS场产生持续、强大影响的可能性很高,为使用
MRI生物标志物指导SCS干预,最终改善SCI患者的临床管理。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The presence or absence of midsagittal tissue bridges and walking: a retrospective cohort study in spinal cord injury.
中矢状组织桥的存在或不存在和行走:脊髓损伤的回顾性队列研究。
- DOI:10.1038/s41393-023-00890-6
- 发表时间:2023
- 期刊:
- 影响因子:2.2
- 作者:Thornton,WA;Marzloff,G;Ryder,S;Best,A;Rasheed,K;Coons,D;Smith,AC
- 通讯作者:Smith,AC
Needs of an uninsured equity-deserving minority patient cohort with physical disabilities during the first wave of the COVID-19 pandemic.
- DOI:10.3389/fresc.2023.1000838
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Claus, D.;Draganich, C.;Berliner, J.;Niehaus, W.;Berliner, J.;Magnusson, D.;Smith, A. C.
- 通讯作者:Smith, A. C.
Muscle adaptations in acute SCI following overground exoskeleton + FES training: A pilot study.
- DOI:10.3389/fresc.2022.963771
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Hohl, Kristen;Smith, Andrew C.;Macaluso, Rebecca;Giffhorn, Matthew;Prokup, Sara;O'Dell, Denise R.;Kleinschmidt, Lina;Elliott, Jim M.;Jayaraman, Arun
- 通讯作者:Jayaraman, Arun
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Craig Smith其他文献
Andrew Craig Smith的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
An atypical microtubule generation mechanism for neurons drives dendrite and axon development and regeneration
神经元的非典型微管生成机制驱动树突和轴突的发育和再生
- 批准号:
23K21316 - 财政年份:2024
- 资助金额:
$ 12.72万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterizing Wnt Signaling Pathways in Axon Guidance
轴突引导中 Wnt 信号通路的特征
- 批准号:
10815443 - 财政年份:2023
- 资助金额:
$ 12.72万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 12.72万 - 项目类别:
Does phosphorylation regulation of the axon initial segment cytoskeleton improve behavioral abnormalities in ADHD-like animal models?
轴突起始段细胞骨架的磷酸化调节是否可以改善 ADHD 样动物模型的行为异常?
- 批准号:
23KJ1485 - 财政年份:2023
- 资助金额:
$ 12.72万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Loss-of-function variants of the axon death protein SARM1 and protection from human neurodegenerative disease
轴突死亡蛋白 SARM1 的功能丧失变体和对人类神经退行性疾病的保护
- 批准号:
2891744 - 财政年份:2023
- 资助金额:
$ 12.72万 - 项目类别:
Studentship
Collaborative Research: Evolution of ligand-dependent Robo receptor activation mechanisms for axon guidance
合作研究:用于轴突引导的配体依赖性 Robo 受体激活机制的进化
- 批准号:
2247939 - 财政年份:2023
- 资助金额:
$ 12.72万 - 项目类别:
Standard Grant
Understanding the degeneration of axon and nerve terminals in Alzheimer's disease and related dementia brain
了解阿尔茨海默病和相关痴呆大脑中轴突和神经末梢的变性
- 批准号:
10661457 - 财政年份:2023
- 资助金额:
$ 12.72万 - 项目类别:
Unlocking BIN1 function in oligodendrocytes and support of axon integrity
解锁少突胶质细胞中的 BIN1 功能并支持轴突完整性
- 批准号:
10901005 - 财政年份:2023
- 资助金额:
$ 12.72万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 12.72万 - 项目类别:
The role of RNA methylation in cytoskeleton regulation during axon development
RNA甲基化在轴突发育过程中细胞骨架调节中的作用
- 批准号:
22KF0399 - 财政年份:2023
- 资助金额:
$ 12.72万 - 项目类别:
Grant-in-Aid for JSPS Fellows